The average pet insurance claim payout, drawn across the published NAPHIA industry data and the cited Consumer Reports buying-guide research, sits well below the all-claims average bill. Two reasons explain the gap: most policies reimburse 70% to 90% of the bill above the deductible (not 100% of the bill), and the most common claim categories on the cited frequency ranking (gastrointestinal disorders, skin and ear conditions, dental disease) are the categories where the deductible erodes the most relative value. The honest payout-to-premium math is closer to neutral on the median policy than the marketing copy suggests, and the right framing for "is pet insurance worth it" is the catastrophic-year case, not the median year.
The numbers from cited claims data
The published industry data places the average annual premium paid for an accident-and-illness policy at $749.29 for dogs and $386.20 for cats in 2024, per NAPHIA's industry section [NAPHIA: Section 3, Average Premiums, 2024]. The same NAPHIA data publishes total payout figures by claim category and total industry premium and claim ratios across the US market. The aggregate loss ratio (total claims paid divided by total premiums collected) on the reviewed-set carriers typically runs in the published industry-data range, with carrier-by-carrier variation that reflects the carrier's claim-process, the policyholder mix's age and breed distribution, and the carrier's pricing strategy [NAPHIA: State of the Industry, Top Conditions, 2024].
The consumer-side data tells a more granular story. Consumer Reports' published buying-guide research, drawn from a survey of 3,583 policyholders, found that only a documented minority of policyholders received full reimbursement at their chosen policy level after the copay [Brian Vines, Consumer Reports Pet Insurance Buying Guide, 2026]. The remaining majority received partial reimbursement (the deductible reduced the eligible portion, or the claim was reduced by the reimbursement-rate copay) or no reimbursement (the claim was denied as pre-existing, inside a waiting period, or otherwise outside the policy's scope).
The average claim payout in the survey-and-industry combined view sits well below the average claim bill, for two load-bearing reasons. The first is the policy structure: the deductible reduces the eligible portion of every claim, and the reimbursement rate (70%, 80%, or 90% at most reviewed carriers) further reduces the amount the carrier returns. On a $1,000 covered claim with a $500 deductible at 80%, the carrier returns $400 and the buyer pays $600; the headline "80% reimbursement" reads as 40% of the actual bill paid by the policy. The second is the claim mix: the most-filed claim categories on the cited NAPHIA ranking are also the ones where the deductible eats the most relative value, because the bills are smaller.
Why the payout-to-premium math runs closer to neutral than buyers expect
Three structural factors drive the gap between premium paid and average payout returned.
The first is the median-year shape. In a typical year, the reviewed-set policy pays out on a small number of claims that are mostly in the cited NAPHIA top-five categories. On the documented top-three (gastrointestinal disorders, skin and ear conditions, dental disease), the typical claim bill is in the low-three-figure to mid-four-figure range, and the deductible plus copay reduces the carrier's payout to a fraction of the bill [NAPHIA: State of the Industry, Top Conditions, 2024]. A median policy year sees the carrier paying meaningfully less than the year's premium.
The second is the catastrophic-year shape. The asymmetry the policy is designed for is the rare year where one claim runs into the upper four or low five figures: a multi-stage cancer course at the cited CareCredit chemotherapy range of $3,000 to $10,000 for a full protocol [CareCredit: How Much Does Chemotherapy for Dogs Cost?, 2025], a cruciate-repair sequence with complications, an emergency surgical case. In those years, the carrier's payout is substantial and the year's premium is a fraction of the return. The policy's value is concentrated in the right-tail year, not the median year.
On a typical reviewed-set policy at $749.29 annual premium for a dog [NAPHIA: Section 3, Average Premiums, 2024]: A median-claim year ($500 covered claims at 80% reimbursement against a $500 deductible) returns near $0 from the policy. A high-frequency-claim year (three to four covered claims totaling $3,000 against the same policy structure) returns about $2,000 from the policy, slightly below the annual premium. A catastrophic-claim year ($10,000 of covered claims in one year, on the cited CareCredit cost ranges [CareCredit: How Much Does CCL (ACL) Surgery for Dogs Cost?, 2025]) returns about $7,600 from the policy, multiples of the annual premium. The honest case is that the policy pays the catastrophic year back, not the median one.
The third is the pre-existing exclusion. The Consumer Reports survey data and the cited NAPHIA frequency ranking both reflect that a documented share of submitted claims is denied or partially denied for pre-existing reasons [Brian Vines, Consumer Reports Pet Insurance Buying Guide, 2026]. A buyer whose pet has chart history at enrollment carries forward more pre-existing flags, which reduces the payout-to-premium ratio further on a per-claim basis.
What the ranking implies for a buyer
The average-payout data is not an indictment of pet insurance; it is a reframe of what the policy is actually for.
The right way to read the payout-to-premium numbers is that the policy is right-tail insurance, priced into the buyer's premium across the policyholder population. On the median year the buyer pays the premium and the policy pays back some fraction of it; on the rare year the policy pays back multiples of the premium. The carrier prices both years into one premium across the population, plus the carrier's margin.
The buyer's decision on whether the policy is "worth it" is not the median-year math. It is whether the buyer can absorb the catastrophic-year cost (the cited CareCredit ranges on cruciate, cancer, foreign-body, hip dysplasia, all in the four-to-five-figure range per case) without insurance, and whether the household has the cash flow and emergency-fund position to take that risk. For most households, the catastrophic-year case is unaffordable without insurance, which is what makes the median-year premium-paid economically rational.
The full case for and against the policy is at is pet insurance worth it, and the most-common-claims-category context is at most common pet insurance claims.
Bottom line
For a buyer running the payout-to-premium math, the right starting point is the catastrophic-year case at the pet's specific breed and age risk profile. A clean-chart young dog of an orthopedic-prone or cancer-prone breed has a catastrophic-year probability high enough that the policy's right-tail value justifies the median-year premium-paid economics. A clean-chart cat with no known breed-linked risk has a lower catastrophic-year probability, and the savings-account self-insurance case is closer to neutral on the lifetime math. The full worth-it case is at is pet insurance worth it, the pre-existing exclusion that shapes paid claims is at pre-existing conditions, and the claim-frequency ranking that drives the payout distribution is at most common pet insurance claims. The review method is at /methodology/.